Vaxil Bio Ltd (VXL) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.042x

Based on the latest financial reports, Vaxil Bio Ltd (VXL) has a cash flow conversion efficiency ratio of -0.042x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-28.00K ≈ $-20.25K USD) by net assets (CA$667.00K ≈ $482.50K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Vaxil Bio Ltd for the company's overall valuation and market capitalisation.

Vaxil Bio Ltd - Cash Flow Conversion Efficiency Trend (2009–2024)

This chart illustrates how Vaxil Bio Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Vaxil Bio Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Vaxil Bio Ltd ranked by their cash flow conversion efficiency. Explore cash flow quality index of Vaxil Bio Ltd to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Europa Oil & Gas Holdings LSE:EOG	-0.080x
Multistack International Ltd AU:MSI	-0.834x
Hemogenyx Pharmaceuticals PLC LSE:HEMO	3.264x
Tongaat JSE:TON	1.602x
Elixxer Ltd V:ELXR	0.024x
Altair Resources Inc V:AVX	0.002x
Annum Bhd KLSE:5082	0.001x
Hawkeye Gold and Diamond Inc V:HAWK	0.031x

Annual Cash Flow Conversion Efficiency for Vaxil Bio Ltd (2009–2024)

The table below shows the annual cash flow conversion efficiency of Vaxil Bio Ltd from 2009 to 2024. View latest Vaxil Bio Ltd stock price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CA$716.00K ≈ $517.94K	CA$-240.00K ≈ $-173.61K	-0.335x	+46.76%
2023-12-31	CA$891.00K ≈ $644.54K	CA$-561.00K ≈ $-405.82K	-0.630x	+2.55%
2022-12-31	CA$1.14 Million ≈ $821.77K	CA$-734.00K ≈ $-530.96K	-0.646x	-1.33%
2021-12-31	CA$1.70 Million ≈ $1.23 Million	CA$-1.08 Million ≈ $-784.15K	-0.638x	+53.52%
2020-12-31	CA$804.00K ≈ $581.60K	CA$-1.10 Million ≈ $-797.89K	-1.372x	-234.20%
2019-12-31	CA$-583.00K ≈ $-421.73K	CA$-596.00K ≈ $-431.14K	1.022x	+147.16%
2018-12-31	CA$435.00K ≈ $314.67K	CA$-943.00K ≈ $-682.15K	-2.168x	-205.47%
2017-12-31	CA$-487.00K ≈ $-352.29K	CA$-1.00 Million ≈ $-724.11K	2.055x	+190.01%
2016-12-31	CA$656.00K ≈ $474.54K	CA$-1.50 Million ≈ $-1.08 Million	-2.284x	-179.41%
2015-12-31	CA$-217.00K ≈ $-156.97K	CA$-624.00K ≈ $-451.39K	2.876x	+176.91%
2014-12-31	CA$34.48K ≈ $24.94K	CA$-128.91K ≈ $-93.25K	-3.739x	-83.25%
2013-12-31	CA$187.94K ≈ $135.95K	CA$-383.44K ≈ $-277.37K	-2.040x	+10.43%
2012-12-31	CA$72.15K ≈ $52.19K	CA$-164.34K ≈ $-118.88K	-2.278x	-31.42%
2011-12-31	CA$264.09K ≈ $191.04K	CA$-457.76K ≈ $-331.14K	-1.733x	-211.04%
2010-12-31	CA$682.06K ≈ $493.39K	CA$-380.10K ≈ $-274.96K	-0.557x	-98.24%
2009-12-31	CA$515.90K ≈ $373.20K	CA$-145.03K ≈ $-104.91K	-0.281x	--

About Vaxil Bio Ltd

V:VXL Canada Biotechnology

Market Cap

$287.36K

CA$397.24K CAD

Market Cap Rank

#31243 Global

#1667 in Canada

Share Price

CA$0.15

Change (1 day)

-3.33%

52-Week Range

CA$0.13 - CA$0.29

All Time High

CA$0.70